Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence [Yahoo! Finance]
Allurion Technologies, Inc. (ALUR)
Company Research
Source: Yahoo! Finance
NATICK, Mass., March 20, 2025 BUSINESS WIRE )--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced initial results on the combination of the Allurion Program with low-dose GLP-1 therapy to optimize muscle mass and GLP-1 adherence. 52 patients treated with the Allurion Balloon were started on 0.25mg semaglutide after completing their first month of balloon therapy. The dose of semaglutide was increased to no greater than 1.0mg over the subsequent 6 months. After 8 months of this combination approach, average total body weight loss was 20.3%, and lean body mass increased by 15% from 59.6% to 68.5%. All patients remained adherent to the GLP-1 medicat
Read more
Impact Snapshot
Event Time:
ALUR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALUR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALUR alerts
High impacting Allurion Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
ALUR
News
- Allurion Technologies Inc. (NYSE: ALUR) had its "neutral" rating re-affirmed by analysts at Chardan Capital. They now have a $2.50 price target on the stock.MarketBeat
- Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business UpdateBusiness Wire
- Allurion Technologies Inc. (NYSE: ALUR) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $16.00 price target on the stock.MarketBeat
- Allurion Technologies Inc. (NYSE: ALUR) had its "neutral" rating re-affirmed by analysts at Chardan Capital. They now have a $2.50 price target on the stock.MarketBeat
ALUR
Earnings
- 3/26/25 - Miss
ALUR
Sec Filings
- 3/27/25 - Form 10-K
- 3/26/25 - Form 8-K
- 3/24/25 - Form DEF
- ALUR's page on the SEC website